Effects of niludipine (Bay a 7168) on the cardiovascular system with a note on its calcium-antagonistic effects. 1979

K Hashimoto, and K Takeda, and Y Katano, and Y Nakagawa, and T Tsukada, and T Hashimoto, and N Shimamoto, and K Sakai, and T Otorii, and S Imai

1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid-bis-(2-propoxyethyl)-ester (niludipine, Bay a 7168), a newly synthesized vasodilator, was three to ten times more potent than nifedipine in dilating the coronary artery of the canine heart-lung and isolated fibrillating heart preparations, but had weaker direct cardiac depressant effects. This drug had a strong and highly selective calcium antagonistic effect on the smooth muscle and also had stronger vasodilating activity on renal and femoral vascular beds as compared to nifedipine. It inhibited myocardial oxidative metabolism in canine and guinea pig hearts.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog

Related Publications

K Hashimoto, and K Takeda, and Y Katano, and Y Nakagawa, and T Tsukada, and T Hashimoto, and N Shimamoto, and K Sakai, and T Otorii, and S Imai
January 1979, Arzneimittel-Forschung,
K Hashimoto, and K Takeda, and Y Katano, and Y Nakagawa, and T Tsukada, and T Hashimoto, and N Shimamoto, and K Sakai, and T Otorii, and S Imai
January 1979, Arzneimittel-Forschung,
K Hashimoto, and K Takeda, and Y Katano, and Y Nakagawa, and T Tsukada, and T Hashimoto, and N Shimamoto, and K Sakai, and T Otorii, and S Imai
January 1979, Arzneimittel-Forschung,
K Hashimoto, and K Takeda, and Y Katano, and Y Nakagawa, and T Tsukada, and T Hashimoto, and N Shimamoto, and K Sakai, and T Otorii, and S Imai
January 1980, Journal of cardiovascular pharmacology,
K Hashimoto, and K Takeda, and Y Katano, and Y Nakagawa, and T Tsukada, and T Hashimoto, and N Shimamoto, and K Sakai, and T Otorii, and S Imai
January 1981, Arzneimittel-Forschung,
K Hashimoto, and K Takeda, and Y Katano, and Y Nakagawa, and T Tsukada, and T Hashimoto, and N Shimamoto, and K Sakai, and T Otorii, and S Imai
January 1982, Arzneimittel-Forschung,
K Hashimoto, and K Takeda, and Y Katano, and Y Nakagawa, and T Tsukada, and T Hashimoto, and N Shimamoto, and K Sakai, and T Otorii, and S Imai
January 1990, Drugs,
K Hashimoto, and K Takeda, and Y Katano, and Y Nakagawa, and T Tsukada, and T Hashimoto, and N Shimamoto, and K Sakai, and T Otorii, and S Imai
January 1972, Comptes rendus des seances de la Societe de biologie et de ses filiales,
K Hashimoto, and K Takeda, and Y Katano, and Y Nakagawa, and T Tsukada, and T Hashimoto, and N Shimamoto, and K Sakai, and T Otorii, and S Imai
October 1985, Archives internationales de pharmacodynamie et de therapie,
K Hashimoto, and K Takeda, and Y Katano, and Y Nakagawa, and T Tsukada, and T Hashimoto, and N Shimamoto, and K Sakai, and T Otorii, and S Imai
November 2013, Atherosclerosis,
Copied contents to your clipboard!